An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2 proof-of-concept study suggest. In the trial, twice […]

Several new studies in lung cancer have opened their doors recently. Is one of your patients eligible to participate? Resected stage II, IIIA, or IIIB with […]

LYON, France — Bempedoic acid (Nexletol) is safe for people with obesity and is effective at lowering lipid levels and rates of major cardiovascular events, according […]

PARIS — Despite some potential advantages, transcatheter aortic valve implantation (TAVI) failed to meet the primary prespecified threshold for noninferiority to surgical aortic valve replacement in […]

New research found women aged 21-65 years who were due for a Papanicolaou (Pap) test to screen for cervical cancer were about 30% less likely in […]

(Reuters) – G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival […]

In October 2023, Robert Card — a grenade instructor in the Army Reserve — shot and killed 18 people in Maine, before turning the gun on […]

BOSTON — A novel, selective registry of high-volume electrophysiologists is helping improve treatments for atrial fibrillation by sharing data and evaluating best practices. The Real-World Experience […]

PARIS — By assessing residual regurgitation after a transcatheter tricuspid valve repair with a four-grade rather than three-grade system, physicians can predict survival more accurately, reported […]